Major Depressive Disorder
Showing NaN - NaN of 78
MDD Trial in United States (Esketamine, Placebo)
Depression, MDD Trial in Canada, United States (Levomilnacipran ER, Placebo)
Completed
- Depression
- Major Depressive Disorder
- Levomilnacipran ER
- Placebo
-
Beverly Hills, California
- +34 more
Dec 23, 2019
MDD Trial in United States (Placebo, Vilazodone)
MDD Trial in United States (Rapastinel (225 mg/450 mg IV administration))
Terminated
- Major Depressive Disorder
- Rapastinel (225 mg/450 mg IV administration)
-
Birmingham, Alabama
- +9 more
Nov 8, 2019
MDD, Dysthymia Disorder Trial in San Diego (Oxytocin, Placebo)
Terminated
- Major Depressive Disorder
- Dysthymia Disorder
- Oxytocin
- Placebo
-
San Diego, CaliforniaUCSD Medical Center
Aug 30, 2019
MDD Trial in Canada, United States (Vilazodone)
Completed
- Major Depressive Disorder
-
Birmingham, Alabama
- +55 more
Sep 10, 2019
MDD Trial in Puerto Rico, United States (Cariprazine, Antidepressant Therapy (ADT))
Completed
- Major Depressive Disorder
- Cariprazine
- Antidepressant Therapy (ADT)
-
Tucson, Arizona
- +89 more
Jul 29, 2019
MDD Trial in Mexico, United States (desvenlafaxine succinate sustained release, fluoxetine, )
Completed
- Major Depressive Disorder
- desvenlafaxine succinate sustained release
- +2 more
-
Dothan, Alabama
- +42 more
Jan 2, 2019
MDD Trial in United States (Switching: Bupropion-SR, Augmenting: Antidepressant + Bupropion-SR, Augmenting: Antidepressant +
Completed
- Major Depressive Disorder
- Switching: Bupropion-SR
- +2 more
-
Tuscaloosa, Alabama
- +34 more
Apr 25, 2018
MDD Trial in United States (vilazodone)
Completed
- Major Depressive Disorder
-
Garden Grove, California
- +37 more
Aug 22, 2017
MDD Trial in San Diego (Approach-positive AAT, Control AAT)
Completed
- Major Depressive Disorder
- Approach-positive AAT
- Control AAT
-
San Diego, CaliforniaUniversity of California, San Diego; Psychiatry Clinical Researc
Aug 31, 2017
MDD Trial in Worldwide (AZD6765 iv, Placebo)
Completed
- Major Depressive Disorder
- AZD6765 iv
- Placebo
-
Chino, California
- +43 more
Apr 10, 2017
MDD Trial in Worldwide (Placebo, RO4917523 0.5 mg, RO4917523 1.5 mg)
Completed
- Major Depressive Disorder
- Placebo
- +2 more
-
Little Rock, Arkansas
- +75 more
Nov 1, 2016
MDD Trial in United States (Lurasidone)
Completed
- Major Depressive Disorder
-
Birmingham, Alabama
- +16 more
Mar 10, 2016
MDD Trial in United States (GLYX-13 5 mg/kg, GLYX-13 10 mg/kg, Placebo)
Completed
- Major Depressive Disorder
- GLYX-13 5 mg/kg
- +2 more
-
Birmingham, Alabama
- +25 more
Feb 18, 2016
MDD, Irritability Trial in United States (Brexpiprazole)
Completed
- Major Depressive Disorder
- Irritability
-
Tucson, Arizona
- +14 more
Feb 16, 2016
MDD Trial in United States (OPC-34712, Placebo, ADT)
NeuroStar TMS Therapy System: Utilization and Outcomes
Completed
- Major Depressive Disorder
-
Phoenix, Arizona
- +43 more
Nov 11, 2015
MDD Trial in United States (ADT, OPC-34712)
Completed
- Major Depressive Disorder
-
Arcadia, California
- +31 more
Oct 6, 2015
MDD Trial in United States (OPC-34712, Placebo, ADT)
MDD Trial in United States (NEST-1 (NeoSync EEG Synchronized TMS), SHAM)
Completed
- Major Depressive Disorder
- NEST-1 (NeoSync EEG Synchronized TMS)
- SHAM
-
Los Angeles, California
- +17 more
Oct 5, 2015
MDD Trial in United States (tasimelteon, )
Completed
- Major Depressive Disorder
- tasimelteon
- placebo
-
Garden Grove, California
- +39 more
Jun 1, 2015
MDD Trial in Worldwide (Placebo, Vilazodone)
Completed
- Major Depressive Disorder
- Placebo
- Vilazodone
-
Beverly Hills, California
- +74 more
May 15, 2015
MDD Trial in United States (Placebo, Escitalopram, JNJ-18038683)
Completed
- Major Depressive Disorder
- Placebo
- +2 more
-
Little Rock, Arkansas
- +25 more
Aug 1, 2014